Global Health Limited (ASX: GLH) has been developing software for the healthcare industry for more than 30 years. Today it announced a new partnership between the company's Lifecard consumer health platform with Asthma Australia. The news sent the Global Health share price rocketing up almost 74% to 40 cents at the time of writing.
What moved the Global health share price?
Almost 3 million Australian's live with asthma. Asthma Australia aims to halve avoidable asthma hospitalisations by 2030. Using the The Lifecard platform, users are able to better manage their health and wellbeing.
Lifecard connects consumers with their care team so they can work in tandem to comply with prescribed care plans. ReferralNet, Global Health's secure message platform, integrates with Lifecard. Consequently, subscribers can receive health and medical information directly into their Lifecard Personal Health Record.
Furthermore, work has begun to integrate Lifecard with wearables and remote monitoring devices. This additional data will provide a more complete and real-time view of a consumer's health, enabling more informed decisions. The company plans to integrate asthma-related data, such as peak expiration flow rate, from wearables.
What did management say?
Global Health managing director Mathew Cherian said:
We are looking forward to the year ahead and what we can achieve together with Asthma Australia. Our shared belief and vision is that the Lifecard platform is an invaluable tool to help consumers manage their long-term conditions and encourage a healthy lifestyle through pro-active engagement.
Asthma Australia CEO Michele Goldman also welcomed the partnership, saying:
People with asthma will often see more than one health professional over the course of time, even multiple visits to different emergency departments. We often hear that people with asthma get rather exhausted retelling their health history, which can be complex and traumatic, and that doctors appreciate the opportunity to assess a health record.
Lifecard is all about more complete information with a holistic picture that enables more insightful conversations between a patient and their doctor. We see this partnership as a great opportunity
for people with asthma to embrace a health tool, and another step toward individualised, person centred health care.
The Global Health share price closed the day up 73.91%.
